CUSIP: 00507W107
Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,245,921
-
Share change
-
+14,565,092
-
Total reported value
-
$5,718,000
-
Price per share
-
$0.25
-
Number of holders
-
38
-
Value change
-
+$3,510,645
-
Number of buys
-
14
-
Number of sells
-
11
Quarterly Holders Quick Answers
What is CUSIP 00507W107?
CUSIP 00507W107 identifies ATNM - ACTINIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2019
-
Previous quarter:
Q1 2019
Recent filing periods for CUSIP 00507W107:
Institutional Holders of ACTINIUM PHARMACEUTICALS INC - COM (ATNM) as of Q2 2019
As of 30 Jun 2019,
ACTINIUM PHARMACEUTICALS INC - COM (ATNM) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,245,921 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, Sio Capital Management, LLC, VANGUARD GROUP INC, Endurant Capital Management LP, PNC Financial Services Group, Inc., Fosun International Ltd, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., NORTHERN TRUST CORP, and OPPENHEIMER & CO INC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.